Joe Schmidt's decision to leave the Wallabies after the 2025 TRC was a surprise despite the signs. Although many believed it ...

At Week 14, 69% (71% of b/tsDMARD-naïve and 66% of b/tsDMARD-experienced) or 220 of the 318 rosnilimab-treated patients across all doses achieved CDAI LDA and were eligible to remain on continued ...

Think rheumatoid arthritis only affects the elderly? Or that exercise makes it worse? Time to bust these myths! We got in ...

With only two weeks remaining in the 2024/2025 tax year, taxpayers have a final opportunity to maximise their tax-deductible ...

AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...

Patients with late-onset rheumatoid arthritis experienced greater functional impairment over 5 years, compared against those with younger-onset disease.

Osiris St. Brown, brother of Detroit Lions wide receiver Amon Ra St. Brown and New Orleans Saints receiver Equanimeous St. Brown, wasn't too impressed by Jalen Hurts' Super Bowl win.

The positive trial results have not only demonstrated rosnilimab's potential in treating RA but have also validated AnaptysBio's scientific approach in targeting PD-1 co-inhibitory receptors on ...

Explore daily insights on the USA TODAY crossword puzzle by . Uncover expert takes and answers in our crossword blog.

This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).

ANSWER: Both RA and MCTD are rheumatologic diseases that affect many systems of the body. MCTD is often considered an overlap ...

Dear D.D.: Both RA and MCTD are rheumatologic diseases that affect many systems of the body. MCTD is often considered an ...